Webinar on the Final Rule on Postmarketing Safety Reporting (PMSR) for Combination Products
The US Food and Drug Administration’s final rule on postmarketing safety reporting for combination products published on December 20, 2016. The FDA’s Office of Combination Products (OCP) presented a webinar on the rule on Friday, February 3, 2017, from 9 to 10 AM, Eastern Standard Time. OCP’s Associate Director for Policy, John Barlow Weiner, Esq., presented the rule, addressed agency plans and expectations relating to it, and responded to questions.
Recorded webinar link: https://collaboration.fda.gov/p30488putvk/?launcher=false&fcsContent=true&pbMode=normal
Webinar presentation: Final Rule on Postmarketing Safety Reporting